Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2018
Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell TumorsCheryl A London, Jaime Acquaviva, Donald L Smith, et al.
Cancer Research|October 12, 2011
Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formationJaime Acquaviva, Hyun Jung Jun, Julie Lessard, et al.
Molecular Cancer Research : MCR|May 3, 2014
FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolismJaime Acquaviva, Suqin He, Chaohua Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2013
Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancerDavid A Proia, Chaohua Zhang, Manuel Sequeira, et al.
Molecular Cancer Therapeutics|August 15, 2015
HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to TumorsDavid A Proia, Donald L Smith, Junyi Zhang, et al.
Cancer Discovery|March 28, 2013
Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancerJim Sang, Jaime Acquaviva, Julie C Friedland, et al.
Pageof 2